Structure
atLeast majority ProS Experiment
:order disorder conflict PDB cluster ProS Pfam Domain SEG
491
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 9-313,428-491 Hetero dimer : IID00631 Complex
Region 4lgd B 9-9 disorder
Region 4lgd B 10-313 order
Region 4lgd B 428-442 disorder
Region 4lgd B 443-488 order
Region 4lgd B 489-491 disorder
Region 4lgd D 9-10 disorder
Region 4lgd D 11-313 order
Region 4lgd D 428-454 disorder
Region 4lgd D 455-489 order
Region 4lgd D 490-491 disorder
Region 4lgd C 9-11 disorder
Region 4lgd C 12-32 order
Region 4lgd C 33-39 disorder
Region 4lgd C 40-313 order
Region 4lgd C 428-436 disorder
Region 4lgd C 437-490 order
Region 4lgd C 491-491 disorder
Region 4lgd A 9-15 disorder
Region 4lgd A 16-313 order
Region 4lgd A 428-436 disorder
Region 4lgd A 437-488 order
Region 4lgd A 489-491 disorder
Region 5dh3 B 15-17 disorder
Region 5dh3 B 18-302 order
Region 5dh3 B 303-313 disorder
Region 5dh3 A 15-18 disorder
Region 5dh3 A 19-307 order
Region 5dh3 A 308-313 disorder
Region 4lg4 F 16-17 disorder
Region 4lg4 F 18-165 order
Region 4lg4 F 166-182 disorder
Region 4lg4 F 183-310 order
Region 4lg4 F 311-313 disorder
Region 4lg4 E 16-17 disorder
Region 4lg4 E 18-33 order
Region 4lg4 E 34-38 disorder
Region 4lg4 E 39-58 order
Region 4lg4 E 59-63 disorder
Region 4lg4 E 64-173 order
Region 4lg4 E 174-179 disorder
Region 4lg4 E 180-308 order
Region 4lg4 E 309-313 disorder
Region 4lg4 D 16-25 disorder
Region 4lg4 D 26-36 order
Region 4lg4 D 37-38 disorder
Region 4lg4 D 39-47 order
Region 4lg4 D 48-51 disorder
Region 4lg4 D 52-57 order
Region 4lg4 D 58-62 disorder
Region 4lg4 D 63-91 order
Region 4lg4 D 92-95 disorder
Region 4lg4 D 96-164 order
Region 4lg4 D 165-182 disorder
Region 4lg4 D 183-308 order
Region 4lg4 D 309-313 disorder
Region 4lg4 C 16-17 disorder
Region 4lg4 C 18-36 order
Region 4lg4 C 37-38 disorder
Region 4lg4 C 39-307 order
Region 4lg4 C 308-313 disorder
Region 4lg4 B 16-17 disorder
Region 4lg4 B 18-35 order
Region 4lg4 B 36-38 disorder
Region 4lg4 B 39-166 order
Region 4lg4 B 167-170 disorder
Region 4lg4 B 171-308 order
Region 4lg4 B 309-313 disorder
Region 4lg4 A 16-17 disorder
Region 4lg4 A 18-35 order
Region 4lg4 A 36-37 disorder
Region 4lg4 A 38-308 order
Region 4lg4 A 309-313 disorder
Seq 16-313,428-491 Hetero dimer : Q9H4B6
Region 6ao5 A 16-27 disorder
Region 6ao5 A 28-46 order
Region 6ao5 A 47-51 disorder
Region 6ao5 A 52-57 order
Region 6ao5 A 58-62 disorder
Region 6ao5 A 63-90 order
Region 6ao5 A 91-94 disorder
Region 6ao5 A 95-168 order
Region 6ao5 A 169-180 disorder
Region 6ao5 A 181-313 order
Region 6ao5 A 428-488 order
Region 6ao5 A 489-491 disorder
Seq 371-401 Hetero pentadecamer : IID00737 Complex
Region 5brm L 371-377 disorder
Region 5brm L 378-382 order
Region 5brm L 383-390 disorder
Region 5brm L 391-397 order
Region 5brm L 398-401 disorder
Region 5brm K 371-377 disorder
Region 5brm K 378-380 order
Region 5brm K 381-390 disorder
Region 5brm K 391-398 order
Region 5brm K 399-401 disorder
Region 5brm J 371-377 disorder
Region 5brm J 378-382 order
Region 5brm J 383-390 disorder
Region 5brm J 391-398 order
Region 5brm J 399-401 disorder
Region 5brm I 371-377 disorder
Region 5brm I 378-381 order
Region 5brm I 382-390 disorder
Region 5brm I 391-398 order
Region 5brm I 399-401 disorder
Region 5brm H 371-376 disorder
Region 5brm H 377-382 order
Region 5brm H 383-388 disorder
Region 5brm H 389-399 order
Region 5brm H 400-401 disorder
Region 5brm O 371-385 disorder
Region 5brm O 386-393 order
Region 5brm O 394-401 disorder
Region 5brm N 371-384 disorder
Region 5brm N 385-396 order
Region 5brm N 397-401 disorder
Region 5brm M 371-379 disorder
Region 5brm M 380-396 order
Region 5brm M 397-401 disorder
Region 5brm G 371-376 disorder
Region 5brm G 377-398 order
Region 5brm G 399-401 disorder
Region 3wws D 436-484 order
Region 3wws C 436-484 order
Region 3wws B 436-484 order
Region 3wws A 436-484 order
Region 4oh9 B 436-484 order
Region 4oh9 A 436-484 order
Region 4l0n J 436-436 disorder
Region 4l0n J 437-484 order
Region 4l0n I 436-484 order
Region 4l0n H 436-484 order
Region 4l0n G 436-484 order
Region 4l0n F 436-484 order
Region 4l0n E 436-484 order
Region 4l0n D 436-484 order
Region 4l0n C 436-484 order
Region 4l0n B 436-484 order
Region 4l0n A 436-484 order
Region 4hkd D 436-484 order
Region 4hkd C 436-484 order
Region 4hkd B 436-484 order
Region 4hkd A 436-484 order
Seq ProS predicted 377-398
Hetero pentadecamer : IID00737 Complex
Region 5brm G 377-398 order
15-15 Phosphoserine; by PLK1
117-117 Phosphothreonine; by PKB/AKT1
174-174 Phosphothreonine; by autocatalysis
180-180 Phosphothreonine; by autocatalysis
384-384 Phosphothreonine; by PKB/AKT1
Prediction
Disorder 1-19,323-448,455-464,472-477,484-491
Order 20-322,449-454,465-471,478-483
ProS 19-19,323-338,360-370,376-383,430-448,455-464,472-477,484-491
Disorder 1-9,37-37,62-62,166-183,196-197,312-429,490-491
Order 10-36,38-61,63-165,184-195,198-311,430-489
Function
Function in SwissProt
Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250. In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259'. Phosphorylates MOBKL1A and RASSF2. Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38.